Measure To Make Drug Makers Disclose Prices In Ads Is Dropped From Appropriations Bill

By John Wilkerson / September 13, 2018 at 3:25 PM
Lawmakers stripped a measure to require that drug companies list prices in drug advertisements from appropriations legislation because it was too controversial with House GOP lawmakers, Senate appropriations conferees said Thursday (Sept. 13). Sens. Charles Grassley (R-IA) and Dick Durbin (D-IL), who wrote the drug ad legislation, criticized conferees for taking out the measure. “It is EMBARRASSING to bow to BIG PHARMA at expense of consumers Policy is supported by Pres Trump+AARP+Dem&GOP Sens If we can agree why are lobbyists...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.